HRT addresses sex hormone deficiency. But menopause isn’t just about estrogen and progesterone. Your growth hormone axis is declining. Your collagen production has cratered. Your metabolic rate has shifted. Your neurotransmitter balance has destabilized. Your immune signaling has changed. HRT doesn’t touch most of these systems. Peptides do.
This guide breaks down the five axes menopause disrupts and maps specific peptides to each one. Whether you’re using HRT and want to fill the gaps, or exploring non-hormonal alternatives, this is the framework.
Growth hormone secretion declines roughly 14% per decade after age 30. By menopause, many women are producing a fraction of the GH they had at 25. This drives muscle loss, increased visceral fat, thinning skin, poor sleep quality, and slower recovery from exercise.
The stack: CJC-1295/Ipamorelin has become the most commonly prescribed peptide combination in women’s health. CJC-1295 extends GH-releasing hormone (GHRH) signaling. Ipamorelin is a selective ghrelin receptor agonist that triggers GH release without significantly affecting cortisol or prolactin — two hormones perimenopausal women are already struggling to regulate.
Taken before bed, this combination enhances the natural GH pulses that occur during deep sleep, improving sleep quality while supporting body composition, skin health, and recovery.
Monitoring: IGF-1 levels. Your provider should test baseline and at 6-8 weeks to ensure levels are optimizing without exceeding the reference range.
Menopause shifts fat storage toward visceral abdominal fat as estrogen declines and insulin sensitivity drops. The Mayo Clinic study showing 30-35% more weight loss when combining GLP-1 therapy with HRT underscores that these axes interact.
The stack: For weight management, the GLP-1 receptor agonists (semaglutide, tirzepatide) have the strongest evidence. For women who don’t qualify for or prefer to avoid GLP-1 drugs, Tesamorelin (FDA-approved for visceral fat reduction) and AOD-9604 (a GH fragment targeting fat metabolism) offer alternative pathways. MOTS-C, a mitochondrial-derived peptide, addresses insulin resistance at the cellular level.
Collagen production drops roughly 30% in the first five years after menopause. Glutathione depletion accelerates rapidly during this same window, driving visible aging.
The stack: GHK-Cu (collagen stimulation, hair follicle support, wound healing) + Glutathione (antioxidant, skin brightening, detoxification) + Epitalon (telomere support, pineal gland function). GHK-Cu can be used both topically (serums, daily skincare) and as an injectable for more systemic effects.
Estrogen modulates serotonin, dopamine, and acetylcholine. When it fluctuates and then declines, these neurotransmitter systems destabilize.
The stack: Selank (anxiolytic + nootropic, morning dosing) + DSIP (sleep architecture, evening dosing). For women whose mood issues include fatigue and brain fog, adding NAD+ supports mitochondrial energy production in neurons. The CJC-1295/Ipa from Axis 1 also contributes here by improving deep sleep quality.
PT-141 (bremelanotide/Vyleesi) is the only FDA-approved treatment for HSDD in premenopausal women. It works through melanocortin receptors in the brain rather than through blood flow. Kisspeptin-10 supports hormonal signaling relevant to the HPO axis. For postmenopausal women, PT-141 remains the primary peptide option — though its FDA approval is specifically for premenopausal HSDD.
| Priority | Stack | Monthly Cost Range |
|---|---|---|
| Foundation | CJC-1295/Ipa + GHK-Cu (topical) | $100-180 |
| Foundation + Sleep/Mood | Above + Selank + DSIP | $180-280 |
| Full Menopause Protocol | CJC-1295/Ipa + Selank + DSIP + GHK-Cu + NAD+ | $280-400 |
| With Weight Management | Any above + semaglutide or tesamorelin | Varies (Rx vs. research) |
A peptide stack is a combination of two or more peptides used together to address multiple biological systems simultaneously. Because menopause affects the GH axis, metabolic system, skin/collagen, mood/sleep, and libido all at once, a single peptide rarely addresses every symptom. Stacking allows you to target each axis with the most appropriate peptide.
Yes — this is the core principle. HRT addresses sex hormone deficiency (estrogen, progesterone). Peptides target the parallel axes that HRT alone doesn't cover: growth hormone secretion, tissue repair, immune signaling, metabolic function. Many integrative providers use both together. Discuss with your provider.
Costs vary significantly depending on which peptides you use and your vendor. A basic stack (GH secretagogue + one support peptide) typically runs $150-300/month through research peptide vendors. FDA-approved options like semaglutide or PT-141 are significantly more expensive but may be covered by insurance with a prescription.
Timeline varies by peptide and goal. Sleep improvements from DSIP or CJC-1295/Ipa are often noticed within 1-2 weeks. Body composition changes take 8-12 weeks. Skin and hair improvements require 3-6 months. Mood and cognitive effects from Selank can appear within days. Set realistic expectations and track progress with your provider.